Human Gene MIR124-1HG (uc003wsw.1)
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
LF210124 - JP 2014500723-A/17627: Polycomb-Associated Non-Coding RNAs. CS266388 - Sequence 80 from Patent WO2005118806. CS266578 - Sequence 270 from Patent WO2005118806. DL076550 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DL076740 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004200 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. DM004390 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. DM176434 - A nucleics Acid regulating cell growth. FU261150 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763652 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV528008 - Nucleic acid controling mast cell degranulation. FW421542 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FW421732 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HH932805 - Sequence 17 from Patent EP2239675. HV304551 - JP 2009531018-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305049 - JP 2009531019-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV970130 - JP 2012523000-A/17: Method for in vitro Diagnosing a Complex Disease. HW119258 - JP 2013046612-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW367413 - JP 2012228254-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW367603 - JP 2012228254-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411806 - JP 2014000079-A/80: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW411996 - JP 2014000079-A/270: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW589587 - JP 2013121348-A/118: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674152 - JP 2014217381-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW674342 - JP 2014217381-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ043186 - JP 2015510401-A/276: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ067094 - JP 2014012020-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ067284 - JP 2014012020-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ081812 - JP 2015514392-A/276: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ408258 - JP 2015528002-A/855: CHIRAL CONTROL. HZ413391 - JP 2014060993-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427518 - JP 2014217384-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ427708 - JP 2014217384-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428321 - JP 2014217385-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428511 - JP 2014217385-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429124 - JP 2014217386-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429314 - JP 2014217386-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429927 - JP 2014217387-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ430117 - JP 2014217387-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ501602 - JP 2016025853-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769184 - JP 2014223080-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ769374 - JP 2014223080-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058578 - Sequence 80 from Patent EP2298893. JA058768 - Sequence 270 from Patent EP2298893. JA059381 - Sequence 80 from Patent EP2298894. JA059571 - Sequence 270 from Patent EP2298894. JA073704 - Sequence 80 from Patent EP2281887. JA073894 - Sequence 270 from Patent EP2281887. JA104841 - Sequence 80 from Patent EP2302051. JA105031 - Sequence 270 from Patent EP2302051. JA106181 - Sequence 80 from Patent EP2302052. JA106371 - Sequence 270 from Patent EP2302052. JA106984 - Sequence 80 from Patent EP2302053. JA107174 - Sequence 270 from Patent EP2302053. JA107787 - Sequence 80 from Patent EP2302054. JA107977 - Sequence 270 from Patent EP2302054. JA108590 - Sequence 80 from Patent EP2302055. JA108780 - Sequence 270 from Patent EP2302055. JA109393 - Sequence 80 from Patent EP2302056. JA109583 - Sequence 270 from Patent EP2302056. JA191909 - Sequence 80 from Patent EP2290066. JA192099 - Sequence 270 from Patent EP2290066. JA192808 - Sequence 80 from Patent EP2290067. JA192998 - Sequence 270 from Patent EP2290067. JA193707 - Sequence 80 from Patent EP2290068. JA193897 - Sequence 270 from Patent EP2290068. JA194606 - Sequence 80 from Patent EP2290069. JA194796 - Sequence 270 from Patent EP2290069. JA195505 - Sequence 80 from Patent EP2290070. JA195695 - Sequence 270 from Patent EP2290070. JA196404 - Sequence 80 from Patent EP2290071. JA196594 - Sequence 270 from Patent EP2290071. JA197303 - Sequence 80 from Patent EP2290072. JA197493 - Sequence 270 from Patent EP2290072. JA198202 - Sequence 80 from Patent EP2290073. JA198392 - Sequence 270 from Patent EP2290073. JA199101 - Sequence 80 from Patent EP2290074. JA199291 - Sequence 270 from Patent EP2290074. JA200000 - Sequence 80 from Patent EP2290075. JA200190 - Sequence 270 from Patent EP2290075. JA200899 - Sequence 80 from Patent EP2290076. JA201089 - Sequence 270 from Patent EP2290076. JA218021 - Sequence 80 from Patent EP2281888. JA218211 - Sequence 270 from Patent EP2281888. JA226172 - Sequence 80 from Patent EP2292755. JA226362 - Sequence 270 from Patent EP2292755. JA229027 - Sequence 80 from Patent EP2292756. JA229217 - Sequence 270 from Patent EP2292756. JA257298 - Sequence 80 from Patent EP2284265. JA257488 - Sequence 270 from Patent EP2284265. JA278578 - Sequence 80 from Patent EP2281886. JA278768 - Sequence 270 from Patent EP2281886. JA284464 - Sequence 80 from Patent EP2281889. JA284654 - Sequence 270 from Patent EP2281889. JA292517 - Sequence 80 from Patent EP2287303. JA292707 - Sequence 270 from Patent EP2287303. JA317703 - Sequence 80 from Patent EP2314688. JA317893 - Sequence 270 from Patent EP2314688. JA374762 - Sequence 80 from Patent EP2322616. JA374952 - Sequence 270 from Patent EP2322616. JA525968 - Sequence 118 from Patent EP2369011. JA526475 - Sequence 118 from Patent EP2369012. JA526982 - Sequence 118 from Patent EP2369013. JA535911 - Sequence 118 from Patent EP2371971. JA787916 - Sequence 118 from Patent EP2479285. JA788414 - Sequence 118 from Patent EP2479286. JA810748 - Sequence 118 from Patent EP2468890. JA811246 - Sequence 118 from Patent EP2468891. JA811744 - Sequence 118 from Patent EP2468893. JA812242 - Sequence 118 from Patent EP2468894. JA812740 - Sequence 118 from Patent EP2468895. JA813238 - Sequence 118 from Patent EP2468896. JA813736 - Sequence 118 from Patent EP2468897. JA814234 - Sequence 118 from Patent EP2468898. JA814732 - Sequence 118 from Patent EP2468899. JA816975 - Sequence 118 from Patent EP2468892. JA825787 - Sequence 118 from Patent EP2471956. JA826285 - Sequence 118 from Patent EP2471958. JB024572 - Sequence 118 from Patent EP2505668. JB025070 - Sequence 118 from Patent EP2505669. JB079457 - Sequence 118 from Patent EP2487252. JB079955 - Sequence 118 from Patent EP2487253. JB080453 - Sequence 118 from Patent EP2487254. JB080951 - Sequence 118 from Patent EP2487255. JB081449 - Sequence 118 from Patent EP2487256. JB081947 - Sequence 118 from Patent EP2487257. JB082445 - Sequence 118 from Patent EP2487258. JB082943 - Sequence 118 from Patent EP2487259. JB083441 - Sequence 118 from Patent EP2487260. JB083939 - Sequence 118 from Patent EP2487261. JB084437 - Sequence 118 from Patent EP2487262. JB084935 - Sequence 118 from Patent EP2487263. JB087613 - Sequence 118 from Patent EP2502630. JB147817 - Sequence 118 from Patent EP2484782. JB148315 - Sequence 118 from Patent EP2484783. JB153040 - Sequence 118 from Patent EP2514433. JB153538 - Sequence 118 from Patent EP2514434. JB622127 - Sequence 118 from Patent EP2586454. JB622625 - Sequence 118 from Patent EP2586455. JC001688 - Sequence 118 from Patent EP2591794. JC221605 - Sequence 80 from Patent EP2471923. JC221795 - Sequence 270 from Patent EP2471923. JC268171 - Sequence 80 from Patent EP2471924. JC268361 - Sequence 270 from Patent EP2471924. JC340479 - Sequence 80 from Patent EP2471922. JC340669 - Sequence 270 from Patent EP2471922. JC469725 - Sequence 80 from Patent EP2471921. JC469915 - Sequence 270 from Patent EP2471921. JC990514 - Sequence 80 from Patent EP2808390. JC990704 - Sequence 270 from Patent EP2808390. LF128872 - JP 2016507218-A/3: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124. LF404283 - JP 2015509366-A/276: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF714617 - JP 2016165292-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF714807 - JP 2016165292-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856551 - JP 2015142597-A/80: METHODS AND COMPOSITIONS INVOLVING MicroRNA. LF856741 - JP 2015142597-A/270: METHODS AND COMPOSITIONS INVOLVING MicroRNA. LG051592 - KR 1020150036642-A/858: CHIRAL CONTROL. LP643472 - Sequence 1 from Patent WO2015041809. LP909361 - Sequence 22 from Patent EP3214174. LY505008 - KR 1020170032361-A/1: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES. LZ228168 - JP 2017524341-A/26: HYBRID TRNA/PRE-MIRNA MOLECULES AND METHODS OF USE. LZ229979 - JP 2017522313-A/1: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES. MA353814 - JP 2018075017-A/276: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. FU261154 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763656 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HV304555 - JP 2009531018-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305053 - JP 2009531019-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW119262 - JP 2013046612-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW589591 - JP 2013121348-A/122: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HZ413395 - JP 2014060993-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501606 - JP 2016025853-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. JA525972 - Sequence 122 from Patent EP2369011. JA526479 - Sequence 122 from Patent EP2369012. JA526986 - Sequence 122 from Patent EP2369013. JA535915 - Sequence 122 from Patent EP2371971. JA787920 - Sequence 122 from Patent EP2479285. JA788418 - Sequence 122 from Patent EP2479286. JA810752 - Sequence 122 from Patent EP2468890. JA811250 - Sequence 122 from Patent EP2468891. JA811748 - Sequence 122 from Patent EP2468893. JA812246 - Sequence 122 from Patent EP2468894. JA812744 - Sequence 122 from Patent EP2468895. JA813242 - Sequence 122 from Patent EP2468896. JA813740 - Sequence 122 from Patent EP2468897. JA814238 - Sequence 122 from Patent EP2468898. JA814736 - Sequence 122 from Patent EP2468899. JA816979 - Sequence 122 from Patent EP2468892. JA825791 - Sequence 122 from Patent EP2471956. JA826289 - Sequence 122 from Patent EP2471958. JB024576 - Sequence 122 from Patent EP2505668. JB025074 - Sequence 122 from Patent EP2505669. JB079461 - Sequence 122 from Patent EP2487252. JB079959 - Sequence 122 from Patent EP2487253. JB080457 - Sequence 122 from Patent EP2487254. JB080955 - Sequence 122 from Patent EP2487255. JB081453 - Sequence 122 from Patent EP2487256. JB081951 - Sequence 122 from Patent EP2487257. JB082449 - Sequence 122 from Patent EP2487258. JB082947 - Sequence 122 from Patent EP2487259. JB083445 - Sequence 122 from Patent EP2487260. JB083943 - Sequence 122 from Patent EP2487261. JB084441 - Sequence 122 from Patent EP2487262. JB084939 - Sequence 122 from Patent EP2487263. JB087617 - Sequence 122 from Patent EP2502630. JB147821 - Sequence 122 from Patent EP2484782. JB148319 - Sequence 122 from Patent EP2484783. JB153044 - Sequence 122 from Patent EP2514433. JB153542 - Sequence 122 from Patent EP2514434. JB622131 - Sequence 122 from Patent EP2586454. JB622629 - Sequence 122 from Patent EP2586455. JC001692 - Sequence 122 from Patent EP2591794. JB974703 - Sequence 14 from Patent EP2684962. JC107388 - Sequence 14 from Patent WO2013175446. CS083365 - Sequence 99 from Patent WO2005040419. CS548258 - Sequence 1288 from Patent EP1777301. DJ003745 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ027024 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ061811 - Oligonucleotide Microarray. DJ087825 - Novel miRNA molecules isolated from human embryonic stem cell. DM119566 - Targeting Cells With Altered miRNA Expression. FU261406 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763908 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FV527637 - Nucleic acid controling mast cell degranulation. FW311998 - DETECTING NUCLEIC ACIDS. FZ415731 - JP 2010536372-A/11: METHODS OF USING MIRNA FOR DETECTION OF IN VIVO CELL DEATH. HV304807 - JP 2009531018-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305305 - JP 2009531019-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV534416 - WO 2011111715-A/932: Nucleic acid for controlling cell cycle. HV954035 - JP 2012518421-A/947: METHODS OF DETECTING LUNG CANCER. HW119514 - JP 2013046612-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW589843 - JP 2013121348-A/374: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HZ075001 - JP 2013535982-A/1092: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ075036 - JP 2013535982-A/1127: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ413647 - JP 2014060993-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501858 - JP 2016025853-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. JA526224 - Sequence 374 from Patent EP2369011. JA526731 - Sequence 374 from Patent EP2369012. JA527238 - Sequence 374 from Patent EP2369013. JA536167 - Sequence 374 from Patent EP2371971. JA715165 - Sequence 947 from Patent EP2401406. JA788172 - Sequence 374 from Patent EP2479285. JA788670 - Sequence 374 from Patent EP2479286. JA811004 - Sequence 374 from Patent EP2468890. JA811502 - Sequence 374 from Patent EP2468891. JA812000 - Sequence 374 from Patent EP2468893. JA812498 - Sequence 374 from Patent EP2468894. JA812996 - Sequence 374 from Patent EP2468895. JA813494 - Sequence 374 from Patent EP2468896. JA813992 - Sequence 374 from Patent EP2468897. JA814490 - Sequence 374 from Patent EP2468898. JA814988 - Sequence 374 from Patent EP2468899. JA817231 - Sequence 374 from Patent EP2468892. JA826043 - Sequence 374 from Patent EP2471956. JA826541 - Sequence 374 from Patent EP2471958. JB024828 - Sequence 374 from Patent EP2505668. JB025326 - Sequence 374 from Patent EP2505669. JB079713 - Sequence 374 from Patent EP2487252. JB080211 - Sequence 374 from Patent EP2487253. JB080709 - Sequence 374 from Patent EP2487254. JB081207 - Sequence 374 from Patent EP2487255. JB081705 - Sequence 374 from Patent EP2487256. JB082203 - Sequence 374 from Patent EP2487257. JB082701 - Sequence 374 from Patent EP2487258. JB083199 - Sequence 374 from Patent EP2487259. JB083697 - Sequence 374 from Patent EP2487260. JB084195 - Sequence 374 from Patent EP2487261. JB084693 - Sequence 374 from Patent EP2487262. JB085191 - Sequence 374 from Patent EP2487263. JB087869 - Sequence 374 from Patent EP2502630. JB148073 - Sequence 374 from Patent EP2484782. JB148571 - Sequence 374 from Patent EP2484783. JB153296 - Sequence 374 from Patent EP2514433. JB153794 - Sequence 374 from Patent EP2514434. JB622383 - Sequence 374 from Patent EP2586454. JB622881 - Sequence 374 from Patent EP2586455. JC001944 - Sequence 374 from Patent EP2591794. JC334102 - Sequence 20 from Patent EP2487240. JE869374 - Sequence 15 from Patent WO2015131115. LF636230 - JP 2016519076-A/4: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS. LG134387 - KR 1020150131312-A/4: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS. LY409570 - KR 1020160122850-A/15: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER. MA264552 - JP 2017507955-A/15: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER. DM175326 - A nucleics Acid regulating cell growth. FW362670 - MICRORNA EXPRESSION SIGNATURE FOR PREDICTING SURVIVAL AND METASTASES IN HEPATOCELLULAR CARCINOMA. FW363975 - Oligonucleotides for modulating target RNA activity. HI377377 - Sequence 4 from Patent EP2087135. HI539271 - Sequence 95 from Patent EP2160477. HI965545 - Sequence 830 from Patent WO2010139812. HI966146 - Sequence 466 from Patent WO2010139811. HI967012 - Sequence 466 from Patent WO2010139810. HV335766 - JP 2011093892-A/9: Tumor proliferation suppressor comprising tumor suppressive micro RNA. HV515808 - JP 2011177139-A/1: A method for detecting cancer and a cancer-suppressing agent. HV515809 - JP 2011177139-A/2: A method for detecting cancer and a cancer-suppressing agent. HV515810 - JP 2011177139-A/3: A method for detecting cancer and a cancer-suppressing agent. HV540982 - WO 2011125469-A/26: A recombinant vaccinia virus regulated by miRNA and use thereof. HV582952 - JP 2010527616-A/93: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS. HV593817 - JP 2010538610-A/30: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. HV594787 - JP 2010539959-A/168: Micromirs. HW044137 - WO 2012161124-A/10: A composition comprising a miRNA or an expression system of said miRNA. HW062431 - JP 2012530054-A/1: METHODS, SYSTEMS, AND COMPOSITIONS FOR NEURONAL DIFFERENTIATION OF MULTIPOTENT STROMAL CELLS. HW120867 - WO 2013038737-A/30: Bladder cancer marker. HW289777 - JP 2013520158-A/20: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION. HW413642 - WO 2014003053-A/91: Method for screening pancreatic cancer and test kit therefor. HZ043080 - JP 2015510401-A/170: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ043081 - JP 2015510401-A/171: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ043082 - JP 2015510401-A/172: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ043408 - JP 2015510401-A/498: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ074080 - JP 2013535982-A/171: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ081706 - JP 2015514392-A/170: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ081707 - JP 2015514392-A/171: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ081708 - JP 2015514392-A/172: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ157344 - JP 2015130862-A/168: Micromirs. HZ186288 - JP 2015146814-A/37: Oligonucleotides for modulating target RNA activity. HZ392514 - JP 2015180203-A/20: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION. HZ432160 - JP 2014207909-A/93: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS. HZ479676 - JP 2015535430-A/182: TERMINALLY MODIFIED RNA. HZ489617 - JP 2016020328-A/17: ANTICANCER AGENT. HZ789607 - JP 2016504050-A/1352: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401583 - Sequence 830 from Patent WO2011080318. JA402561 - Sequence 830 from Patent WO2011080315. JA403568 - Sequence 830 from Patent WO2011080316. JA406199 - Sequence 830 from Patent EP2336353. JA426979 - Sequence 312 from Patent WO2011072177. JA429725 - Sequence 830 from Patent WO2011095623. JA660646 - Sequence 100 from Patent WO2011131354. JA667976 - Sequence 55 from Patent WO2011139911. JB022310 - Sequence 152 from Patent WO2013026685. JB022990 - Sequence 244 from Patent WO2013026684. JB359245 - Sequence 1 from Patent EP2440660. JB620256 - Sequence 236 from Patent WO2013063544. JB835717 - Sequence 7 from Patent WO2013057567. JC032816 - Sequence 88 from Patent WO2013160474. JC037631 - Sequence 159 from Patent EP2643479. JC512339 - Sequence 2592 from Patent WO2014113089. JC529345 - Sequence 4 from Patent WO2014111892. JC531658 - Sequence 78 from Patent WO2014082644. JC583729 - Sequence 13 from Patent WO2014095922. JC583737 - Sequence 21 from Patent WO2014095922. JC605384 - Sequence 4 from Patent EP2757161. JE978655 - Sequence 100 from Patent EP2865765. LF128871 - JP 2016507218-A/2: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124. LF161437 - JP 2016513950-A/1503: Oligomers with improved off-target profile. LF404177 - JP 2015509366-A/170: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF404178 - JP 2015509366-A/171: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF404179 - JP 2015509366-A/172: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF404477 - JP 2015509366-A/470: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF857581 - JP 2015130879-A/30: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. LG099946 - KR 1020150109407-A/4: miRNA-124 as a biomarker. LP643475 - Sequence 4 from Patent WO2015041809. LP714635 - Sequence 7 from Patent WO2015092707. LP726772 - Sequence 466 from Patent EP2883966. LP764390 - Sequence 1 from Patent WO2018051293. LP819042 - Sequence 466 from Patent EP3296406. LP909341 - Sequence 2 from Patent EP3214174. LP931135 - Sequence 111 from Patent EP3224347. LP938984 - Sequence 466 from Patent EP3184651. LQ069927 - Sequence 251 from Patent EP2964234. LQ500616 - Sequence 30 from Patent EP3048177. LQ660986 - Sequence 7 from Patent EP3090058. LQ724653 - Sequence 286 from Patent WO2018096084. LV539139 - JP 2016539127-A/140: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE. LX282466 - JP 2016505268-A/4: miRNA-124 as a biomarker. LY298541 - KR 1020160079824-A/140: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE. LY404852 - KR 1020160117535-A/157: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY505011 - KR 1020170032361-A/4: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES. LZ229982 - JP 2017522313-A/4: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES. LZ233645 - JP 2017184756-A/37: Oligonucleotides for modulating target RNA activity. MA149258 - JP 2018504093-A/111: INDUCED HEPATOCYTES AND USES THEREOF. MA260091 - JP 2017505623-A/157: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA353708 - JP 2018075017-A/170: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA353709 - JP 2018075017-A/171: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA353710 - JP 2018075017-A/172: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA354008 - JP 2018075017-A/470: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MS673441 - Sequence 244 from Patent EP3135774. MS834684 - Sequence 830 from Patent EP3112479. MS901679 - Sequence 152 from Patent EP3156505. MS904114 - Sequence 30 from Patent EP3138926. MS930514 - Sequence 7 from Patent EP3178943. CS166346 - Sequence 57 from Patent WO2005078096. CS265322 - Sequence 64 from Patent EP1627925. CS444377 - Sequence 64 from Patent WO2006108473. DL231894 - Method for the determination of cellular transcriptional regulation. AY940852 - Homo sapiens microRNA hsa-mir-RG-110, complete sequence. FW363976 - Oligonucleotides for modulating target RNA activity. HI965544 - Sequence 829 from Patent WO2010139812. HI966190 - Sequence 510 from Patent WO2010139811. HI967056 - Sequence 510 from Patent WO2010139810. HV594788 - JP 2010539959-A/169: Micromirs. HW044133 - WO 2012161124-A/6: A composition comprising a miRNA or an expression system of said miRNA. HZ074079 - JP 2013535982-A/170: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ157345 - JP 2015130862-A/169: Micromirs. HZ186289 - JP 2015146814-A/38: Oligonucleotides for modulating target RNA activity. HZ479681 - JP 2015535430-A/187: TERMINALLY MODIFIED RNA. HZ789612 - JP 2016504050-A/1357: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401582 - Sequence 829 from Patent WO2011080318. JA402560 - Sequence 829 from Patent WO2011080315. JA403567 - Sequence 829 from Patent WO2011080316. JA406198 - Sequence 829 from Patent EP2336353. JA426928 - Sequence 261 from Patent WO2011072177. JA429724 - Sequence 829 from Patent WO2011095623. JA791745 - Sequence 147 from Patent WO2012089772. JB022610 - Sequence 452 from Patent WO2013026685. JB023179 - Sequence 433 from Patent WO2013026684. JB175141 - Sequence 173 from Patent WO2012101219. JB620255 - Sequence 235 from Patent WO2013063544. JC512344 - Sequence 2597 from Patent WO2014113089. JC529346 - Sequence 5 from Patent WO2014111892. JC531657 - Sequence 77 from Patent WO2014082644. JC605385 - Sequence 5 from Patent EP2757161. LF128870 - JP 2016507218-A/1: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124. LF160288 - JP 2016513950-A/354: Oligomers with improved off-target profile. LG099947 - KR 1020150109407-A/5: miRNA-124 as a biomarker. LP643474 - Sequence 3 from Patent WO2015041809. LP726816 - Sequence 510 from Patent EP2883966. LP769539 - Sequence 66 from Patent EP3294910. LP819086 - Sequence 510 from Patent EP3296406. LP909342 - Sequence 3 from Patent EP3214174. LP939028 - Sequence 510 from Patent EP3184651. LQ069932 - Sequence 256 from Patent EP2964234. LX282467 - JP 2016505268-A/5: miRNA-124 as a biomarker. LY404853 - KR 1020160117535-A/158: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY417028 - KR 1020160145093-A/134: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY. LY505012 - KR 1020170032361-A/5: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES. LZ229983 - JP 2017522313-A/5: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES. LZ233646 - JP 2017184756-A/38: Oligonucleotides for modulating target RNA activity. MA260092 - JP 2017505623-A/158: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MS673630 - Sequence 433 from Patent EP3135774. MS816789 - Sequence 138 from Patent WO2017085287. MS834683 - Sequence 829 from Patent EP3112479. MS901979 - Sequence 452 from Patent EP3156505. MA643428 - JP 2017113010-A/1352: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731312 - JP 2017140048-A/182: TERMINALLY MODIFIED RNA. MA643433 - JP 2017113010-A/1357: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731317 - JP 2017140048-A/187: TERMINALLY MODIFIED RNA. MA400879 - JP 2018515097-A/66: Method for Diagnosis and Prognosis of Chronic Heart Failure. LQ955699 - Sequence 30 from Patent EP2775001. MA445701 - JP 2018138019-A/17627: Polycomb-Associated Non-Coding RNAs. MP045454 - Sequence 276 from Patent EP3401394. MP084124 - Sequence 276 from Patent EP3401393. MP045348 - Sequence 170 from Patent EP3401394. MP045349 - Sequence 171 from Patent EP3401394. MP045350 - Sequence 172 from Patent EP3401394. MP045648 - Sequence 470 from Patent EP3401394. MP070427 - Sequence 24 from Patent WO2018231851. MP084018 - Sequence 170 from Patent EP3401393. MP084019 - Sequence 171 from Patent EP3401393. MP084020 - Sequence 172 from Patent EP3401393. MA800481 - JP 2018183181-A/1352: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA800486 - JP 2018183181-A/1357: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA852125 - JP 2019022498-A/3: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124. MA852124 - JP 2019022498-A/2: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124. MA852123 - JP 2019022498-A/1: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124. MP264353 - Sequence 347 from Patent WO2019086603. MP264354 - Sequence 348 from Patent WO2019086603. MP280781 - Sequence 201 from Patent WO2019111197. MP283694 - Sequence 201 from Patent WO2019111198. MP452209 - Sequence 3 from Patent EP3591036. MP452208 - Sequence 2 from Patent EP3591036. MP452207 - Sequence 1 from Patent EP3591036.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: MIR124-1, NR_029668 UCSC ID: uc003wsw.1 RefSeq Accession: NR_029668
| |
|
|
Gene Model Information
|
|
category:
| noncoding
| nonsense-mediated-decay:
| no
| RNA accession:
| NR_029668.1
|
exon count:
| 1 | CDS single in 3' UTR:
| no
| RNA size:
| 85 |
ORF size:
| 0 | CDS single in intron:
| no
| Alignment % ID:
| 100.00 |
txCdsPredict score:
| 148.50 | frame shift in genome:
| no
| % Coverage:
| 100.00 |
has start codon:
| no
| stop codon in genome:
| no
| # of Alignments:
| 1 |
has end codon:
| no
| retained intron:
| no
| # AT/AC introns
| 0 |
selenocysteine:
| no
| end bleed into intron:
| 0 | # strange splices:
| 0 |
|
Click here
for a detailed description of the fields of the table above.
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|